PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.49420185041175-1185Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer OnlySu-Jin Shin, Hosub Park, You-Na Sung, Changhoon Yoo, Dae Wook Hwang, Jin-hong Park, Kyu-pyo Kim, Sang Soo Lee, Baek-Yeol Ryoo, Dong-Wan Seo, Song Cheol Kim, Seung-Mo Honghttp://e-crt.org/upload/pdf/crt-2017-494.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.494, http://www.e-crt.org/upload/pdf/crt-2017-494.pdf
Lung Cancer10.1016/s0169-5002(05)81491-6200549S383-S38420 Synchronous and metachronous lung cancer other than adenocarcinoma in women with breast cancerP. Berzinec, J. Detvayhttps://api.elsevier.com/content/article/PII:S0169500205814916?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500205814916?httpAccept=text/plain
European Journal of Cancer Supplements10.1016/s1359-6349(08)71433-220086967The genetic future of pathology: of pancreatic cancer and other malignancieshttps://api.elsevier.com/content/article/PII:S1359634908714332?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634908714332?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)94477-6199411182Clinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancershttps://api.elsevier.com/content/article/PII:0169500294944776?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294944776?httpAccept=text/plain
PET/CT in Hepatobiliary and Pancreatic Malignancies10.1007/978-3-319-60507-4_2201713-20Pathology of Hepatobiliary and Pancreatic CancerKedar Deodharhttp://link.springer.com/content/pdf/10.1007/978-3-319-60507-4_2
The Journal of Pathology: Clinical Research10.1002/cjp2.820151276-82Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs)Koji Imai, Hidenori Karasaki, Yusuke Ono, Junpei Sasajima, Shin-ichi Chiba, Hiroshi Funakoshi, Miho Muraki, Hideki Hanaoka, Takahisa Furukawa, Hiroyuki Furukawa, Toru Kono, Kazuo Nagashima, Yusuke Mizukamihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcjp2.8, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcjp2.8, https://onlinelibrary.wiley.com/doi/full/10.1002/cjp2.8
Surgery Today10.1007/s00595-018-1738-42018494343-349Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancerHiroaki Komatsu, Nobuhiro Izumi, Takuma Tsukioka, Hidetoshi Inoue, Kantaro Hara, Hikaru Miyamoto, Noritoshi Nishiyamahttp://link.springer.com/content/pdf/10.1007/s00595-018-1738-4.pdf, http://link.springer.com/article/10.1007/s00595-018-1738-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00595-018-1738-4.pdf
Multimodality Management of Borderline Resectable Pancreatic Cancer10.1007/978-3-319-22780-1_182016289-306The Role of Irreversible Electroporation and Other Ablative Techniques in Patients with Borderline Resectable Pancreatic CancerRobert C. G. Martin, Rachel O’Connorhttp://link.springer.com/content/pdf/10.1007/978-3-319-22780-1_18
Current and Emerging Therapies in Pancreatic Cancer10.1007/978-3-319-58256-6_72017135-149Imaging of Pancreatic MalignanciesFerenc Czeyda-Pommersheim, Bobby Kalb, Diego Martinhttp://link.springer.com/content/pdf/10.1007/978-3-319-58256-6_7
Lung Cancer10.1016/s0169-5002(86)80774-7198624270Synchronous and metachronous lung carcinomas related to malignant primary tumours at other siteshttps://api.elsevier.com/content/article/PII:S0169500286807747?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500286807747?httpAccept=text/plain